<--- Back to Details
First PageDocument Content
Pharmacology / Research / Health / Pharmaceutical industry / European Medicines Agency / Good Laboratory Practice / Pharmacovigilance / Summary of Product Characteristics / Directive 2001/83/EC / Clinical research / Pharmaceutical sciences / Pharmaceuticals policy
Date: 2014-06-03 16:50:48
Pharmacology
Research
Health
Pharmaceutical industry
European Medicines Agency
Good Laboratory Practice
Pharmacovigilance
Summary of Product Characteristics
Directive 2001/83/EC
Clinical research
Pharmaceutical sciences
Pharmaceuticals policy

L[removed]EN Official Journal of the European Union

Add to Reading List

Source URL: www.fve.org

Download Document from Source Website

File Size: 222,21 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document